Latest Clostridium Stories

Brett Smith for redOrbit.com - Your Universe Online While antibiotics like penicillin are great for fighting off bacterial infections, they can also wreak havoc on beneficial gut bacteria, leading to diarrhea and other gastrointestinal problems. New research from scientists at the Cochrane Collaboration found that taking a “pre-emptive” probiotic could prevent diarrhea associated with antibiotics when symptoms are caused by the potentially dangerous Clostridium difficile bacterium....

A recent New Zealand Herald article examines numerous concerns surrounding Botox treatments. Dr. Simon Ourian of Epione Beverly Hills says that Botox has been used safely for cosmetic purposes for more than a decade. Los Angeles, CA (PRWEB) May 21, 2013 According to a May 13, 2013 New Zealand Herald article titled “Time to Rethink the Use of Botox,” Botox injections have become the most popular cosmetic procedure in the world since their approval in 2002 (Go to goo.gl/8iYbD). Although...

ROSEVILLE, Minn., May 1, 2013 /PRNewswire/ -- William "Bill" McGuire, M.D., former chairman and CEO of UnitedHealth Group, has joined the board of directors of Rebiotix Inc. The Roseville, Minn.-based biotechnology company is pioneering a practical and non-antibiotic treatment for recurrent Clostridium difficile infection (CDI) known as Microbiota Restoration Therapy (MRT). CDI has been linked to 14,000 deaths annually in the US, and has become the most common healthcare-associated...

Specialised Therapeutics Australia to Launch DIFICID May 14, 2013 JERSEY CITY, N.J., April 26, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Therapeutic Goods Administration, the Australian regulatory body for therapeutic goods such as medicines, has approved DIFICID® (fidaxomicin) tablets for the treatment of confirmed Clostridium difficile infection (CDI) in adults. DIFICID will be available to patients in Australia starting May 14,...

CHESTERBROOK, Pa., April 25, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the first quarter 2013 on Monday, April 29, 2013 before the opening of the U.S. financial markets. The Company will also conduct a conference call that day at 8:30 a.m. ET to discuss results and highlights of the first quarter. The presentation slides to be used during the call will be available on the "For Investors" section...

CHERTSEY, England, April 19, 2013 /PRNewswire/ -- Clostridiumdifficile infection (CDI), a potentially fatal disease, is one of the most common healthcare-associated infections[1] Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.[2] In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts...

EXTON, Pa., April 8, 2013 /PRNewswire/ -- BioTrends Research Group and Arlington Medical Resources in their TreatmentTrends(®): Clostridium difficile Infections (EU) report find that the lack of hospital formulary inclusion, perceived high cost and reimbursement challenges, and lack of familiarity are the top three barriers to prescribing of Optimer/Cubist/Astellas' Dificlir (fidaxomicin) among surveyed physicians in the EU5. Fewer than 40 percent of represented hospitals in the EU5...

A strain of probiotic bacteria that can fight harmful bacterial infections in poultry has the ability to change its coat, according to new findings from the Institute of Food Research. The probiotic is currently being taken forward through farm-scale trials to evaluate how well it combats Clostridium perfringens – a cause of necrotic enteritis in poultry and the second most common cause of food poisoning in the UK The researchers at IFR, which is strategically funded by the...

Diet Doc’s has advanced their prescription hCG diets to be a more cost-effective and safe alternative to gastric injections of botulinum toxin A (BTA) that are proven to be largely ineffective in fast weight loss. San Francisco, CA (PRWEB) February 21, 2013 Diet Doc’s prescription hCG diets have now been customized to produce fast weight loss at a fraction of the cost of gastric Botox injections, which offer no benefit in terms of body weight loss. Though Botox is one of the most...

In a paper published today in the journal PLOS ONE, scientists from Biolog, Inc. reported on the use of Phenotype MicroArray technology as a general method that enables the determination of environmental signals that can activate or repress production of toxins by pathogenic microorganisms. Hayward, CA (PRWEB) February 20, 2013 Regulation of Microbial Toxin Production: A Novel Application of Biolog’s Phenotype MicroArray™ Technology In a paper published today in the journal PLOS ONE,...